Evidence map›Paper›PMID 36153585›Full record

ArticleBMC biology2022

ARID1A-dependent maintenance of H3.3 is required for repressive CHD4-ZMYND8 chromatin interactions at super-enhancers.

Jake J Reske, Mike R Wilson, Brooke Armistead, Shannon Harkins, Cristina Perez, Joel Hrit, Marie Adams, Scott B Rothbart, Stacey A Missmer, Asgerally T Fazleabas and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Jake J ReskeDepartment of Obstetrics, Gynecology and Reproductive Biology, College of Human Medicine, Michigan State University, Grand Rapids, MI, 49503, USA.
Mike R WilsonDepartment of Obstetrics, Gynecology and Reproductive Biology, College of Human Medicine, Michigan State University, Grand Rapids, MI, 49503, USA.
Brooke ArmisteadDepartment of Obstetrics, Gynecology and Reproductive Biology, College of Human Medicine, Michigan State University, Grand Rapids, MI, 49503, USA.
Shannon HarkinsDepartment of Obstetrics, Gynecology and Reproductive Biology, College of Human Medicine, Michigan State University, Grand Rapids, MI, 49503, USA.
Cristina PerezDepartment of Obstetrics, Gynecology and Reproductive Biology, College of Human Medicine, Michigan State University, Grand Rapids, MI, 49503, USA.
Joel HritDepartment of Epigenetics, Van Andel Research Institute, Grand Rapids, MI, 49503, USA.
Marie AdamsGenomics Core Facility, Van Andel Research Institute, Grand Rapids, MI, 49503, USA.
Scott B RothbartDepartment of Epigenetics, Van Andel Research Institute, Grand Rapids, MI, 49503, USA.
Stacey A MissmerDepartment of Obstetrics, Gynecology and Reproductive Biology, College of Human Medicine, Michigan State University, Grand Rapids, MI, 49503, USA.
Asgerally T FazleabasDepartment of Obstetrics, Gynecology and Reproductive Biology, College of Human Medicine, Michigan State University, Grand Rapids, MI, 49503, USA.
Ronald L ChandlerDepartment of Obstetrics, Gynecology and Reproductive Biology, College of Human Medicine, Michigan State University, Grand Rapids, MI, 49503, USA. rlc@msu.edu.ORCID 0000-0001-5775-2594
Michigan State University · USVan Andel Institute · USSpectrum Health · US

Funding

Molecular mechanisms of chromatin and epigenetic regulationR35GM124736 · NIGMS · VAN ANDEL RESEARCH INSTITUTE · PI ROTHBART, SCOTT · 2017 to 2021
$2.4M
Epigenetic regulatory mechanisms and therapeutic opportunities in endometriosisR01HD103617 · NICHD · MICHIGAN STATE UNIVERSITY · PI CHANDLER, RONALD L · 2021 to 2025
$1.7M
Role of chromatin remodeling and cell signaling in endometriosis etiologyR21HD099383 · NICHD · MICHIGAN STATE UNIVERSITY · PI CHANDLER, RONALD L · 2019 to 2020
$430k
Defining the regulation of UHRF1 and DNMT1 for maintenance of the epigenomeF32CA260116 · NCI · VAN ANDEL RESEARCH INSTITUTE · PI HRIT, JOEL · 2021 to 2023
$208k
NCI NIH HHS F32 CA260116NICHD NIH HHS R01 HD103617NICHD NIH HHS R21 HD099383NIGMS NIH HHS R35 GM124736
6 · The paper itself

Abstract

backgroundSWI/SNF (BAF) chromatin remodeling complexes regulate lineage-specific enhancer activity by promoting accessibility for diverse DNA-binding factors and chromatin regulators. Additionally, they are known to modulate the function of the epigenome through regulation of histone post-translational modifications and nucleosome composition, although the way SWI/SNF complexes govern the epigenome remains poorly understood. Here, we investigate the function of ARID1A, a subunit of certain mammalian SWI/SNF chromatin remodeling complexes associated with malignancies and benign diseases originating from the uterine endometrium.

resultsThrough genome-wide analysis of human endometriotic epithelial cells, we show that more than half of ARID1A binding sites are marked by the variant histone H3.3, including active regulatory elements such as super-enhancers. ARID1A knockdown leads to H3.3 depletion and gain of canonical H3.1/3.2 at ARID1A-bound active regulatory elements, and a concomitant redistribution of H3.3 toward genic elements. ARID1A interactions with the repressive chromatin remodeler CHD4 (NuRD) are associated with H3.3, and ARID1A is required for CHD4 recruitment to H3.3. ZMYND8 interacts with CHD4 to suppress a subset of ARID1A, CHD4, and ZMYND8 co-bound, H3.3+ H4K16ac+ super-enhancers near genes governing extracellular matrix, motility, adhesion, and epithelial-to-mesenchymal transition. Moreover, these gene expression alterations are observed in human endometriomas.

conclusionsThese studies demonstrate that ARID1A-containing BAF complexes are required for maintenance of the histone variant H3.3 at active regulatory elements, such as super-enhancers, and this function is required for the physiologically relevant activities of alternative chromatin remodelers.

Indexed as

ChromatinDNA-Binding ProteinsHistonesTranscription FactorsChromatin Assembly and DisassemblyDNAFemaleHumansMi-2 Nucleosome Remodeling and Deacetylase ComplexNucleosomesARID1A protein, humanCHD4 protein, humanChromatinDNADNA-Binding ProteinsHistonesMi-2 Nucleosome Remodeling and Deacetylase ComplexNucleosomesTranscription FactorsARID1AChromatinEndometriomaEndometriumGene expressionH3.3NuRDRemodelingSWI/SNFVariant histone

Identifiers

PMID36153585
PMCPMC9509632
OpenAlexW4297201037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.